D.K. Enterprises Global Limited

D.K. Enterprises Global Limited

NNSE:DKEGL
69.50
INR
-0.45
(-0.64%)
473.00MMarket Cap
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
60.02
86.19
145.89
184.45
190.96
206.36
225.07
- -
Basic EPS, GAAP
1.99
3.22
5.41
5.73
6.19
7.56
7.59
- -
Free Cash Flow per Basic Share
-6.4
-2.66
0.49
8.89
3.72
3.45
3.42
- -
Dividend per Share
- -
- -
- -
0.5
1.5
2
2
- -
Book Value per Share
4.36
10.8
24.47
29.07
33.12
37.85
42.6
42.6
Tangible Book Value per Share
4.34
10.78
24.46
29.06
33.12
37.85
42.59
42.59
Basic Weighted Avg Shares
8
8
6
8
8
8
8
8
Sales/Revenue/Turnover
451
647
932
1,385
1,434
1,549
1,690
- -
Operating Margin (%)
5.07
5.87
5.18
4.66
4.84
5.36
5.02
- -
Depreciation Expense
3
5
7
8
13
15
17
- -
Net Income, GAAP
15
24
35
43
46
57
57
- -
Effective Tax Rate (%)
27.76
20.39
18.76
28.62
31.71
30.88
31.68
- -
Profit Margin (%)
3.32
3.74
3.71
3.11
3.24
3.66
3.37
- -
Working Capital
2
19
123
135
137
160
117
117
LT Debt
53
36
39
44
21
16
79
79
Total Equity
48
90
194
232
263
305
345
345
Return on Invested Capital (%)
- -
22.12
16.79
14.87
13.82
15.01
12.03
- -
Return on Capital (%)
- -
21.97
17.39
15.74
15.29
16.43
13.02
- -
Return on Common Equity (%)
- -
42.53
26.11
21.4
19.91
21.29
18.88
- -

Capital Structure

INR

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
ST Debt
83
59
118
LT Borrowings
16
15
79
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8
8
8
Market Capitalization
521
559
473

Working Capital

INR

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
Total Current Assets
404
508
489
Cash, Cash Equivalents & STI
106
107
72
Accounts Receivable, Net
172
230
201
Inventories
81
122
159
Total Current Liabilities
244
334
372
Payables & Accruals
- -
- -
- -
ST Debt
83
59
118
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
35.63%
13.11%
Free Cash Flow
- -
368.45%
-0.98%
Net Income, GAAP
- -
19.57%
0.48%
Sales/Revenue/Turnover
- -
22.66%
9.07%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1,434
2025
- -
- -
1,549
2026
- -
- -
1,690

Semi-annual Earnings Per Share

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
6.19
2025
- -
- -
7.56
2026
- -
- -
7.59

Semi-annual Dividends Per Share

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1.5
2025
- -
- -
2
2026
- -
- -
2

Company Description

CEO
Rakesh Kumar
Full Time Employees
85
Sector
Process industries
Industry
Containers/Packaging
Address
Plot Number-235, Industrial Area Panchkula HA India 134109
IPO Date
Oct 22, 2021
Website
dkegl.com
Business
D.K. Enterprises Global Ltd. manufactures and sells sustainable flexible packaging materials, self-adhesive tapes, and laminated products from manufacturing facilities in Haryana, Gujarat, and Himachal Pradesh, India. The company offers a range of paper-based packaging materials, including printed corrugated sleeve rolls and boxes, printed die-cut boxes, duplex board sleeves, and cartons; self-adhesive tapes such as BOPP tapes, easy release/soap banding tapes, promotional shelf strips, clear and printed BOPP tapes, advertising tapes, masking tapes, siliconized tapes, medical tapes, and surface protection tapes; and laminated products comprising dry lamination products, extrusion lamination coated/sandwich products, and soap wrappers with hot melt coating. It operates through four business segments: BOPP Tape and Laminates, Corrugated Sheets and Boxes, Soap Stiffener, and Wrapper; and primarily serves multinational corporations in the consumer goods sector, including clients such as Vodafone Idea and Patanjali Ayurved. Incorporated in 2019 and headquartered in Panchkula, Haryana, the company, formerly known as D.K. Enterprises Global Hub Limited, changed its name in April 2019 and holds ISO 9001:2015 and ISO 14001:2015 certifications. In September 2025, D.K. Enterprises Global Ltd. agreed to acquire 100% equity in Superior Biotec Private Limited for INR 10 million in cash, with the transaction expected to complete between September 27, 2025, and March 31, 2026, making Superior Biotec its wholly owned subsidiary. Also in September 2025, the company re-appointed Managing Director Rakesh Kumar and Whole-Time Director Rekha Bansal for five-year terms, along with Independent Director J.P. Singhvi and secretarial auditor Vishal Arora.